Advanced search    

Search: authors:"Mel DeCorby"

5 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Patients in Canadian Hospitals in 2007

BACKGROUND: In 2008, ceftobiprole was approved by Health Canada for the treatment of patients with complicated skin and skin structure infections including diabetic foot infections; approval of ceftobiprole by the United States Food and Drug Administration is pending. Doripenem is currently under review by Health Canada and was approved by the United States Food and Drug...

Analysis of 1560 Inpatient and Outpatient Escherichia coli Isolates from across Canada—Results from the CANWARD 2007 Study

OBJECTIVES: Escherichia coli was the most common pathogen isolated in the Canadian Ward Surveillance Study (CANWARD 2007) and remains one of the most common pathogens isolated in all health care settings. An in-depth analysis of all E coli isolates was performed to determine the distribution and demographics associated with resistance to antimicrobials, presence of extended...

Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007

Antimicrobial susceptibility of 6685 organisms isolated from Canadian hospitals: CANWARD 2007 George G Zhanel Mel DeCorby Msc Kim A Nichol MSc Aleksandra Wierzbowski MSc Patricia J Baudry MSc Franil

Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007

Antimicrobial susceptibility of 6685 organisms isolated from Canadian hospitals: CANWARD 2007 George G Zhanel Mel DeCorby Msc Kim A Nichol MSc Aleksandra Wierzbowski MSc Patricia J Baudry MSc Franil